NCT05138471

Brief Summary

Knee osteoarthritis has a very high prevalence in the population over 50 years of age. Patients with osteoarthritis often suffer from chronic pain that becomes disabling, affecting both quality of life and mental and physical health. This pathology has also been linked to maladaptive plasticity in the brain, which can contribute to chronic pain. Therapies with neuromodulatory approaches, such as transcranial direct current stimulation (tDCS) and peripheral electrical stimulation (TENS), have been used therapeutically to counteract the maladaptive plasticity of the brain. Transcranial therapy and TENS can be a possible effective treatment in the rehabilitation services of the health system for the improvement of chronic pain and quality of life in different pathologies, such as chronic low back pain, fibromyalgia or knee and hip osteoarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

November 17, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 1, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

May 8, 2024

Status Verified

January 1, 2024

Enrollment Period

2.3 years

First QC Date

October 4, 2021

Last Update Submit

May 7, 2024

Conditions

Keywords

tDCStranscranial direct current stimulationknee osteoarthritisTENSchronic knee pain

Outcome Measures

Primary Outcomes (1)

  • Chronic Knee Pain

    The Visual Analogic Scale will be used to assess the impact on chronic knee pain. The values range from 0 to 10 (0 = No pain, 10 = the worst pain).

    Through study completion, an average of 1 year.

Secondary Outcomes (9)

  • Function and Quality of Life

    Through study completion, an average of 1 year.

  • Force

    Through study completion, an average of 1 year.

  • Balance

    Through study completion, an average of 1 year.

  • Gait properties.

    Through study completion, an average of 1 year.

  • Coordination and Balance

    Through study completion, an average of 1 year.

  • +4 more secondary outcomes

Study Arms (3)

tDCS Active vs TENS Active

EXPERIMENTAL
Device: transcranial direct current stimulation (tDCS)Device: TENSBehavioral: Exercise and General Education

tDCS Active vs TENS Placebo

EXPERIMENTAL
Device: transcranial direct current stimulation (tDCS)Behavioral: Exercise and General Education

tDCS Placebo vs TENS Placebo

PLACEBO COMPARATOR
Behavioral: Exercise and General Education

Interventions

tDCS intervention will consist in placing two electrodes, the cathode on the supraorbital surface on the same side as the painful knee, and the anode on the parietal area, corresponding to the area of the primary motor cortex, on the opposite side. The intensity will be 2 milli amperes (mA) and stimulation will be 20 minutes. The placebo will generate an initial sensation, and then descend until the stimulation is turned off.

tDCS Active vs TENS ActivetDCS Active vs TENS Placebo
TENSDEVICE

TENS intervention will consist in placing two electrodes on the sides of the patella of the affected knee. The frequency will be 10Herzts and the intensity will remain at a sensitive threshold level, without reaching the motor. The placebo will generate a sensation of current to descend to the minimum value that the equipment allows. Stimulation will last for 20 minutes.

tDCS Active vs TENS Active

The General Education Intervention consisting in an educational program will be applied to all groups using audiovisual material to increase the subject's knowledge about his/her pathology, about chronic pain and recommendations for supervised exercise based on the NEMEX protocol for osteoarthritis (Ageberg et al.)18: the participants will be taught analytical strengthening exercises (quadriceps and hamstrings) and neuromuscular functional exercises (getting up from the chair or going up a step), with their detailed dosage (2 to 3 series with 10 to 15 repetitions) and a home follow-up model where the participant must record compliance with exercise as well as pain during activity.

tDCS Active vs TENS ActivetDCS Active vs TENS PlacebotDCS Placebo vs TENS Placebo

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over fifty years of age with a diagnosis of knee osteoarthritis by radiography.
  • Chronic pain of more than six months, compliance with the diagnostic criteria for knee osteoarthritis according to the Osteoarthritis Research Society International (OARSI) guideline:
  • Pain in Analog Visual Scale more than 4/10
  • Matutinal less than 30 minutes
  • Absence of hyperthermia upon palpation in the joint
  • Alteration of the bone image
  • Crepitus

You may not qualify if:

  • Patients who can provide low-quality or biased information discriminated by the Mini-Mental State Examination (Score less than 24).
  • Severe hearing, visual or sensory impairment or comorbidities that prevent the correct completion of the questionnaires and mobility activities.
  • Patients who have undergone knee replacement surgery on the contralateral knee.
  • Patients who have received intervention (infiltration, blockages, etc...) in the last 6 weeks.
  • Pain due to tendinopathy, knee fracture, low back pain radiating to the knee, or fibromyalgia.
  • Patients who decline to participate out of fear or denial of therapy.
  • Severe heart disease that prevent exercise.
  • Body Mass Index above 45.
  • Patients with neuropsychiatric disorders (schizophrenia, epilepsy or bipolar disorders) or taking medication for these conditions (antiepileptic drugs).
  • Patients with metallic implants in the area (skull or knee).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Murcia

Murcia, 30100, Spain

Location

MeSH Terms

Conditions

Chronic PainOsteoarthritis, Knee

Interventions

Transcranial Direct Current StimulationTranscutaneous Electric Nerve StimulationExercise

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and AnalgesiaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Joaquina JM Montilla, PhD, PT

    Director

    STUDY DIRECTOR
  • Mariano MG Gacto, PhD, PT

    Co-Director

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2021

First Posted

December 1, 2021

Study Start

November 17, 2021

Primary Completion

March 1, 2024

Study Completion

May 1, 2024

Last Updated

May 8, 2024

Record last verified: 2024-01

Locations